Elevance Health Inc. closed 31.17% below its 52-week high of $567.26, which the company reached on September 3rd.

We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click ...

Shares of Elevance Health Inc. ELV slipped 1.42% to $405.40 Tuesday, on what proved to be an all-around great trading session ...

After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

U.S. stocks rose to a record as Wall Street regained some of the momentum that catapulted it to 57 all-time highs last year.

Elevance Health Inc.'s stock rose 2% Thursday and boosted other health-insurance stocks after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor concerns ...

For the quarter ended December 2024, Elevance Health (ELV) reported revenue of $44.99 billion, up 6% over the same period last year. EPS came in at $3.84, compared to $5.62 in the year-ago quarter.

Elevance Health delivered earnings and 2025 guidance that broadly met analysts’ expectations, likely providing some relief to investors after a challenging quarter. The fourth-quarter results ...

Shares of Elevance Health jumped early Thursday in response to better-than-expected fourth- quarter results, and a generally optimistic outlook for the coming year. A week after UnitedHealth Group ...

Financial giants have made a conspicuous bullish move on Elevance Health. Our analysis of options history for Elevance Health ELV revealed 12 unusual trades. Delving into the details, we found 50% ...

CI), CVS Health (NYSE:CVS), Humana (NYSE:HUM), Molina Healthcare (NYSE:MOH), and UnitedHealth Group (NYSE:UNH) saw an upswing following Elevance Health's latest quarterly results. Elevance Health, ...